Literature DB >> 15273716

CAS promotes invasiveness of Src-transformed cells.

Jan Brábek1, Sábata S Constancio, Nah-Young Shin, Ambra Pozzi, Alissa M Weaver, Steven K Hanks.   

Abstract

CAS ('Crk-associated substrate') is an Src substrate found at sites of integrin-mediated cell adhesion and linked to cell motility and survival. In this study, the involvement of CAS in oncogenic transformation was evaluated through analysis of mouse embryo fibroblast populations expressing an activated Src mutant, either in the presence or absence of CAS expression. CAS was not found to be a critical determinant of either Src-mediated morphologic transformation or anchorage-independent growth. However, CAS had a profound effect on other aspects of oncogenic Src function. CAS expression led to a substantial increase in the phosphotyrosine content of FAK and paxillin, supporting a role for CAS as a positive regulator of Src activity at integrin adhesion sites. Importantly, CAS expression resulted in a striking enhancement of the capacity of Src-transformed cells to invade through Matrigel. The increased invasiveness was associated with increased activation of matrix metalloproteinase MMP-2 and formation of large actin-rich podosomal aggregates appearing as ring and belt structures. Thus, elevated CAS-associated tyrosine phosphorylation signaling events occurring at sites of integrin-mediated cell adhesion can have a major role in the development of an invasive cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273716     DOI: 10.1038/sj.onc.1207965

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected].

Authors:  Yingchun Wang; Jonathan A Kelber; Hop S Tran Cao; Greg T Cantin; Rui Lin; Wei Wang; Sharmeela Kaushal; Jeanne M Bristow; Thomas S Edgington; Robert M Hoffman; Michael Bouvet; John R Yates; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation.

Authors:  Laura C Kelley; Amanda Gatesman Ammer; Karen E Hayes; Karen H Martin; Kazuya Machida; Lin Jia; Bruce J Mayer; Scott A Weed
Journal:  J Cell Sci       Date:  2010-10-27       Impact factor: 5.285

3.  Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth.

Authors:  Parag Patwardhan; Yongquan Shen; Gary S Goldberg; W Todd Miller
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

Review 4.  Invadopodia: specialized cell structures for cancer invasion.

Authors:  Alissa M Weaver
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

Review 5.  Processive phosphorylation: mechanism and biological importance.

Authors:  Parag Patwardhan; W Todd Miller
Journal:  Cell Signal       Date:  2007-06-22       Impact factor: 4.315

6.  Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry.

Authors:  Eugene Ciccimaro; Steven K Hanks; Kenneth H Yu; Ian A Blair
Journal:  Anal Chem       Date:  2009-05-01       Impact factor: 6.986

7.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

8.  Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.

Authors:  Michael S Guerrero; J Thomas Parsons; Amy H Bouton
Journal:  Genes Cancer       Date:  2012-05

9.  The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation.

Authors:  Matthew D Buschman; Paul A Bromann; Pilar Cejudo-Martin; Fang Wen; Ian Pass; Sara A Courtneidge
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

10.  Global impact of oncogenic Src on a phosphotyrosine proteome.

Authors:  Weifeng Luo; Robbert J Slebos; Salisha Hill; Ming Li; Jan Brábek; Ramars Amanchy; Raghothama Chaerkady; Akhilesh Pandey; Amy-Joan L Ham; Steven K Hanks
Journal:  J Proteome Res       Date:  2008-06-19       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.